Phenomenal paper just published in Science persuasively demonstrating that EBV causes most if not all multiple sclerosis.
Phenomenal epidemiological design and technical achievement. 👏
https://t.co/LcNFvKHiUp
Today, Ensoma is thrilled to welcome gene and cell therapy pioneer, Dr. Emile Nuwaysir, as our new CEO to lead our team forward as we advance our bigger, bolder vision for gene therapy. Learn more here. https://t.co/P4P8td46yn
Pear is pleased to announce the first participant has been enrolled in the @NIH clinical trial investigating combinations of pharmacological and behavioral interventions to treat #opioid use disorder (#OUD). Learn more about the clinical trial: https://t.co/ToZdDNz6LQ. #PDTs
Industry and policymakers must embrace pragmatic drug pricing reforms. A Guest Commentary by @amicusrx1's John Crowley and @5amVentures' Kush Parmar https://t.co/Z8xnOsA3pq
Together with @PallCorporation and @Cytiva, we will further enable development of transformative medicines to improve the lives of patients. Learn more: https://t.co/J6HmCzifCK
Our founders and the entire TMRW team are excited to announce @TaraComonte as our new CEO, starting May 2021. Learn more about our founding board member and the current President and CFO of Shake Shack here: https://t.co/2zLF1RGX7x
The Vasan Lab is recruiting postdoctoral scientists, graduate students, lab technicians, and clinical collaborators to join our team starting in July 2021! Please visit our lab webpage https://t.co/YGSSE95nYM, or email [email protected] for more information.
@CabalettaBio announces 1st patient dosed in landmark DesCAARTes™ trial of DSG3-CAART for treatment of patients with mucosal-dominant pemphigus vulgaris #CAART#autoimmune#CellTherapy
https://t.co/tn6PTU2utM
UPDATE: We are proud to announce, along with @BioNTech_Group, that our mRNA-based #vaccine candidate has, at an interim analysis, demonstrated initial evidence of efficacy against #COVID19 in participants without prior evidence of SARS-CoV-2 infection.
#SARSCoV2 sequence first published in January.
In <10 months, we have 1st #COVID19 vaccine w/ >90% efficacy in a large Ph3 trial.
This is truly unprecedented in vaccine development and thanks to everyone who worked tirelessly to make it happen. #Biotech innovation at its best!
Pear is thrilled to announce @TheHartford is supporting its employees and their families with benefit coverage of our prescription digital therapeutics for #SUD and #OUD. Learn more: https://t.co/ZaMH40n3LH #PDTs#NationalRecoveryMonth
Our own @lhpeng discusses the role of #deeplearning in diagnosing diatbetic retinopathy and more with @anikagupta18 on the most recent episode of #thedatapulse podcast. Click the link below to listen:
Thrilled to introduce The Data Pulse, a podcast that dives into the growing role that data science plays in the latest biomedical innovations. Tune in weekly for ~30 min as I speak with pioneers of data-driven human health. https://t.co/HbzEJ9pHqJ 1/7